IP Verse

Human Blood-Derived Products Having Decreased Fibrinolytic Activity And Uses Thereof In Hemostatic Disorders

Patent No. EP3506915 (titled "Human Blood-Derived Products Having Decreased Fibrinolytic Activity And Uses Thereof In Hemostatic Disorders") was filed by Plas Free on Aug 31, 2017. The application was issued on Mar 6, 2024.

Patent Summary

Patent Family

Patent Family

Patent Oppositions (2)

Patent oppositions filed by competitors challenge the validity of a granted patent. These oppositions are typically based on claims of prior art, lack of novelty, or non-obviousness. They are a key part of the process for determining a patent's strength and enforceability.

CompanyOpposition DateRepresentative
BIOTESTDec 5, 2024TER MEER STEINMEISTER & PARTNER
MARCHANTDec 4, 2024MURGITROYD

Dossier Documents

The dossier documents provide a comprehensive record of the patent's prosecution history - including filings, correspondence, and decisions made by patent offices - and are crucial for understanding the patent's legal journey and any challenges it may have faced during examination.

  • Date

    Description

  • Get instant alerts for new documents

EP3506915

PLAS FREE
Application Number
EP17768525A
Filing Date
Aug 31, 2017
Status
Granted And Under Opposition
Feb 2, 2024
Publication Date
Mar 6, 2024
External Links
Slate, Register , Google Patents